Deng, Y., Cai, Y., Lin, J., Jiang, L., & Hu, H. (2015). Survival of patients with KRAS wild-type metastatic colorectal cancer is identical after sequential treatment with cetuximab and bevacizumab regardless of the sequence – A retrospective single-center study. Gastroenterol Rep (Oxf).
Chicago Stili AlıntıDeng, Yanhong, Yue Cai, Jiayu Lin, Ling Jiang, ve Huabin Hu. "Survival of Patients With KRAS Wild-type Metastatic Colorectal Cancer Is Identical After Sequential Treatment With Cetuximab and Bevacizumab Regardless of the Sequence – A Retrospective Single-center Study." Gastroenterol Rep (Oxf) 2015.
MLA AlıntıDeng, Yanhong, et al. "Survival of Patients With KRAS Wild-type Metastatic Colorectal Cancer Is Identical After Sequential Treatment With Cetuximab and Bevacizumab Regardless of the Sequence – A Retrospective Single-center Study." Gastroenterol Rep (Oxf) 2015.